Stay updated on Nal-Irinotecan & Nivolumab in Biliary Cancer Clinical Trial

Sign up to get notified when there's something new on the Nal-Irinotecan & Nivolumab in Biliary Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nal-Irinotecan & Nivolumab in Biliary Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error instead of the expected study content, indicating restricted access to the record.
    Difference
    19%
    Check dated 2026-09-21T22:21:41.000Z thumbnail image
  3. Check
    14 days ago
    No Change Detected
  4. Check
    21 days ago
    No Change Detected
  5. Check
    28 days ago
    Change Detected
    Summary
    The site footer now shows Revision: v3.6.6, replacing the previous revision. This indicates a minor deployment/version label update.
    Difference
    0.1%
    Check dated 2026-08-31T16:49:16.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The site revision label was updated from v3.6.4 to v3.6.5, indicating a software update to the platform. No study content or user-facing information appears to have changed.
    Difference
    0.0%
    Check dated 2026-08-10T12:33:25.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.3 to v3.6.4, signaling a new version of the page and its metadata.
    Difference
    0.0%
    Check dated 2026-07-27T05:52:15.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.2 to v3.6.3, indicating a new site build; no study content or critical information appears to be altered.
    Difference
    0.0%
    Check dated 2026-07-05T13:19:40.000Z thumbnail image
  9. Check
    93 days ago
    Change Detected
    Summary
    The page's revision indicator has been updated from v3.6.0 to v3.6.2. This reflects a metadata update rather than any substantive changes to trial information or content.
    Difference
    0.0%
    Check dated 2026-06-28T08:38:42.000Z thumbnail image

Stay in the know with updates to Nal-Irinotecan & Nivolumab in Biliary Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nal-Irinotecan & Nivolumab in Biliary Cancer Clinical Trial page.